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Abstract: The proteome of the postsynaptic terminal of excitatory synapses comprises over one
thousand proteins in vertebrate species and plays a central role in behavior and brain disease.
The brain is organized into anatomically distinct regions and whether the synapse proteome differs
across these regions is poorly understood. Postsynaptic proteomes were isolated from seven forebrain
and hindbrain regions in mice and their composition determined using proteomic mass spectrometry.
Seventy-four percent of proteins showed differential expression and each region displayed a unique
compositional signature. These signatures correlated with the anatomical divisions of the brain
and their embryological origins. Biochemical pathways controlling plasticity and disease, protein
interaction networks and individual proteins involved with cognition all showed differential regional
expression. Combining proteomic and connectomic data shows that interconnected regions have
specific proteome signatures. Diversity in synapse proteome composition is key feature of mouse
and human brain structure.
Keywords: synapse; postsynaptic; proteome; mass spectrometry; protein interaction networks;
connectome
1. Introduction
Synapses are the specialized junctions between nerve cells and are present in vast numbers in
the mammalian nervous system. During the 1990s, synapses were thought to be relatively simple
connectors, but the application of proteomic mass spectrometry in 2000 revealed an unanticipated
complexity in their protein composition [1]. Both the presynaptic and postsynaptic proteomes have
since been systematically characterized in several vertebrate species and thousands of proteins have
been identified [2–13]. Phosphoproteomic studies have shown that neural activity causes changes
in large numbers of proteins [14,15]. These findings have transitioned the view of synapses to
one where they are highly sophisticated and complex signaling machines that process information.
The importance of understanding this complexity is underscored by the finding that over 130 human
brain diseases are caused by mutations disrupting postsynaptic proteins [16,17].
It is of fundamental importance to understand how the high number of postsynaptic proteins
are organized physically (within synapses) and spatially (between synapses). Biochemical studies
have shown that postsynaptic proteins are typically assembled into a hierarchy of complexes and
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supercomplexes (complexes of complexes) [18–20]. The prototype of postsynaptic supercomplexes are
those formed by the scaffolding protein PSD95 (also known as Dlg4). Dimers of PSD95 assemble with
complexes of neurotransmitter receptors, ion channels, signaling and structural proteins into a family
of high molecular weight (1–3 MDa) structures in excitatory synapses [18–20]. PSD93 (also known
as Dlg2), which is a paralog of PSD95, co-assembles with PSD95 to bind N-methyl-D-aspartate
(NMDA) receptors and these are an important functional subset of the PSD95 supercomplex family.
Other combinations of proteins form other subtypes of PSD95 supercomplexes, such as those
containing potassium channels and serotonin receptors [20–23]. Together, these members of the
PSD95 supercomplex family confer diverse signal processing functions to the synapse.
The principles underlying the spatial organization of synapse proteomes in the brain is less well
understood. To date, most studies of the synapse proteome have focused on defining composition from
limited regions of the brain (or the whole brain). However, at the macroscopic level, brain architecture
is characterized by regions with distinct functions [24]. It is therefore of importance to ask if synapse
proteomes differ between brain regions and whether any differences might be relevant to their function
or to the connectivity between these regions. In a recent study, we reported that regions of human
neocortex differ in the composition of their postsynaptic proteomes and that these compositional
differences correlate with functional properties [25]. The present study employs a similar analysis
applied to the mouse brain, which allows us to ask if conserved principles may apply across these two
species that evolved from a common ancestor ~90 million years ago.
Using a method suitable for the isolation and direct quantification of mouse synapse proteomes
from small amounts of brain tissue, we compared and contrasted the synapse proteomes isolated from
seven integral regions of the adult mouse brain. The postsynaptic proteome was analyzed to a depth
of 1173 proteins and differential expression signatures were identified and characterized in each brain
region. We used these datasets to analyze the spatial organization of the postsynaptic proteome in
the mouse brain and identify organizational principles shared with humans [25,26]. This large-scale
dataset is a useful resource for the field of neuroscience and future studies using mouse models of
human disease.
2. Materials and Methods
2.1. Dissections of Mouse Brain Regions
This study was performed using 8-week-old male C57BL/6J mice. All experimental protocols
involving the use of animals were performed in accordance with recommendations for the proper care
and use of laboratory animals and under the authorization of the regulations and policies governing
the care and use of laboratory animals (EU directive No. 86/609 and Council of Europe Convention
ETS123, EU decree 2001-486 and Statement of Compliance with Standards for Use of Laboratory
Animals by Foreign Institutions No. A5388-01, National Institutes of Health, Bethesda, MD, USA).
The mice (n = 6) were anesthetized with a pentobarbital dose of 40 mg/kg body weight and
sacrificed by decapitation. The brains were rapidly removed and kept on ice while the areas of interest
were dissected from the right hemisphere using the microdissection method of Palkovits [27]. Large
regions were collected from the frontal, medial and caudal cortex, as well as the right caudate putamen,
right hippocampus, whole hypothalamus, and cerebellum (right half), which was cut previously
through the vermis (Figure S1). The samples were frozen on liquid nitrogen and stored at −80 ◦C
until processed.
2.2. PSD Isolation and Protein Preparations for Mass Spectrometry
Dissected mouse brain regions were homogenized by performing 12 strokes with a Dounce
homogenizer containing 2 mL ice-cold homogenization buffer (320 mM sucrose, 1 mM HEPES,
pH 7.4) containing 1× Complete EDTA-free protease inhibitor (Roche) and 1× Phosphatase inhibitor
cocktail set II (Calbiochem). Synaptosomes were isolated from homogenized mouse brain tissue as
Proteomes 2018, 6, 31 3 of 18
described [2]. Briefly, insoluble material was pelleted by centrifugation at 1000× g for 10 min at 4 ◦C.
The supernatant (S1) was removed and the pellet resuspended in 1 mL homogenization buffer and an
additional six strokes were performed. Following a second centrifugation at 1000× g for 10 min at
4 ◦C, the supernatant (S2) was removed and pooled with S1. The combined supernatants were then
centrifuged at 18,500× g for 15 min at 4 ◦C. The pellet was resuspended in 0.25 mL homogenization
buffer and 0.25 mL extraction buffer (50 mM NaCl, 1% DOC, 25 mM Tris-HCl, pH 8.0) containing
1× Complete EDTA-free protease inhibitor (Roche) and 1× Phosphatase inhibitor cocktail set II
(Calbiochem) and incubated on ice for 1 h. The resulting PSD extracts were centrifuged at 10,000× g
for 20 min at 4 ◦C and the resulting supernatant filtered through a 0.2 µm syringe filter (Millipore).
2.3. Sample Preparation and LC-MS/MS Analysis
All chemicals were purchased from Sigma-Aldrich unless otherwise stated. Acetonitrile and
water for HPLC-MS/MS and sample preparation were HPLC quality and were purchased from
Thermo Fisher Scientific (Loughborough, UK). Formic acid was supra-pure (90–100%) purchased
from Merck KGaA (Darmstadt, Germany) while trypsin sequencing grade was purchased from
Promega (Southampton, UK). All HPLC-MS connector fittings were either purchased from Upchurch
Scientific (Hichrom) or Valco (RESTEK). Fifty micrograms of PSD proteins were acetone precipitated,
protein pellets reconstituted in SDS-PAGE loading buffer, and briefly run on a 4–12% Bis-Tris gradient
gel (Invitrogen) for ~10 min. Proteins were in-gel digested using a method similar to that of
Shevchenko et al. (2006) [28]. Resulting peptide extracts were then acidified with 7 µL 0.05% TFA and
were filtered with a Millex filter (Millipore) before HPLC-MS analysis. Nano-HPLC-MS/MS analysis
was performed using an on-line system consisting of a nano-pump (Dionex Ultimate 3000, Thermo
Fisher) coupled to a QExactive instrument (Thermo Fisher) with a pre-column of 300 µm × 5 mm
(Acclaim Pepmap, 5 µm particle size) connected to a column of 75 µm× 50 cm (Acclaim Pepmap, 3 µm
particle size). Samples were analyzed on a 90-min gradient in data-dependent analysis (one survey
scan at 70 k resolution followed by the top ten MS/MS).
2.4. Mass Spectrometry and Data Analysis
Data from MS/MS spectra were searched using MASCOT version 2.4 (Matrix Science Ltd.,
London, UK) against the Mus musculus subset of the National Center for Biotechnology Information
(NCBI) protein database (382,487 protein sequences) with maximum missed-cut value set to 2.
The following features were used in all searches: (i) variable methionine oxidation; (ii) fixed cysteine
carbamidomethylation; (iii) precursor mass tolerance of 10 ppm; (iv) MS/MS tolerance of 0.05 amu;
(v) significance threshold (p) below 0.05 (MudPIT scoring); and (vi) final peptide score of 20.
Progenesis version 4 (Nonlinear Dynamics, Newcastle upon Tyne, UK) was used for HPLC-MS
label-free quantitation. Only MS/MS peaks with a charge of 2+, 3+ or 4+ were considered for the
total number of “Feature” (signal at one particular retention time and m/z) and only the five most
intense spectra per “Feature” were included. Each LC-MS run was normalized by multiplying a scalar
factor. The scalar factor is a ratio in log space of the median intensity of the selected features against
the median intensity of the selected feature of a reference spectrum. The associated unique peptide ion
intensities for a specific protein were then summed to generate an abundance value and transformed
using an ArcSinH function. Based on the abundance values, within group means were calculated and
from there the fold changes (in comparison to control) were evaluated. One-way analysis of variance
(ANOVA) was used to calculate the p-value based on the transformed abundance values. p-values were
adjusted for multiple comparisons and were calculated either from Progenesis version 4 (Nonlinear
Dynamics) or using R (R Core Team, 2013) [29] based on Benjamini and Hochberg (1995) [30]. Further
analysis was performed by extracting a Z-score calculated on ArcSinH average group.
Differentially expressed proteins were only considered significant in the current study if the
following conditions were fulfilled: (i) adjusted p-values (pairwise) less than 0.05; (ii) number of
unique peptides detected and used in quantification per protein was at least 2 for the 1173 dataset;
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and (iii) absolute fold change was at least 1.3 for differentially abundant proteins and ≤0.667 for
downregulated proteins.
2.5. Bioinformatic Analyses
The majority of the analysis was performed in the R software environment for statistical
computing and graphics. Principal component analysis (PCA) and Tukey test was performed with
R package FactoMineR and correlation analysis with the package corrplot. Differential stability (DS)
analysis was performed as described [31]; briefly, for each protein from the list of 1173, the average
Pearson correlation coefficient was estimated from 14 pairwise Pearson coefficients for six brain
samples. Based on DS, Tukey and PCA analyses, we determined that the data from all six individuals
could be combined and the mean protein abundances were then used for all downstream analyses.
Heatmaps were generated with use of the heatmap.2 function from gplot R library: parameters were
set to default values with the exception of label and dendrogram visualization control. Hierarchical
clustering validation and comparison of dendrograms were performed with package dendextend [32].
The number of stable clusters was independently assessed with nbclust package [33], which provides
the list of indices to determine the optimal number of clusters. We selected a set of six clusters
[the postsynaptic proteome modules (PPMs)] based on the best combination of indices provided by
nbclust R package. Individual proteins in each of the six PPMs and their abundances across all seven
integral regions are listed in Table S5 and proteins in each module were ranked by their abundance in
each of the seven regions of the mouse brain examined.
We used Bioconductor package ClusterProfiler for Gene Ontology (GO) and KEGG enrichment
analysis [34] and Bioconductor ReactomePA package for pathway over-representation analysis
(http://bioconductor.org/packages/release/bioc/html/ReactomePA.html).
GO function and KEGG pathway enrichment for all proteins was performed using DAVID
(https://david.ncifcrf.gov/). Disease enrichment for each brain region and each protein module
was performed using DAVID (https://david.ncifcrf.gov/) and KEGG pathway enrichment was then
performed by searching ranked protein lists obtained using GSea version 2.1.0 (http://software.
broadinstitute.org/gsea/index.jsp) as previously described [35].
Circular hierarchical clustering of protein modules for the visualization of inter-region molecular
interactions was performed using Circos (http://circos.ca) [36]. A Circos configuration file was created
representing brain regions as “karyotypes”. All proteins were grouped into “modules” according
to their abundance similarity. Proteins that have positive abundance in more than one region were
shown as links between regions. The width of each link is proportional to the fraction of the regional
proteins that contributed to the link, while its color corresponds to that of the respective “module”.
All preprocessing of the relative abundance information and generation of appropriate Circos files
were performed in R. Scripts are available on request.
For DS analysis, we used the described approach [31] on the MS intensity values obtained for all
1173 proteins identified with a minimum of two unique peptides in order to identify synaptic proteins
with highly reproducible expression patterns across all six independent mouse brains. The average
pairwise Pearson correlation ρ over the six individual mouse brains was quantified and obtained
DS values ranged from 0.96 to −0.22 (avgCor, Table S3). As DS reflects the tendency of a gene to
exhibit reproducible differential expression relationships across brain structures, the higher DS value
represents a more reproducible relationship.
For correlation with mesoscale mouse connectome data [37], the mean voxel sum for each region
was calculated with respect to all other regions and itself. The correlation of this matrix was then
estimated with the matrix of protein abundances. The results are listed in Table S3.
2.6. Protein Interaction Identification and Mapping
The full postsynaptic proteome network was built from the list of 1173 proteins obtained in
this study and protein-protein interactions (PPIs) obtained by mining publicly available databases:
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BioGRID [38], IntAct [39] and DIP [40] both for mouse and human. The total network consists
of 1016 proteins and 8105 PPIs. We applied weights to each interaction based on abundance
values for specific brain regions as follows: mean (ExpA, ExpB), so that for each of the regions
the specific weight for each of the interactions could be determined. Having varying abundances for
interacting proteins in different brain regions, we estimated the region-specific edge that resulted in
region-specific PPI. Each brain region network was clustered making use of the spectral properties of
the network; the network being expressed in terms of its eigenvectors and eigenvalues, and partitioned
recursively (using a fine-tuning step) into communities based on maximizing the clustering measure
modularity [41–43]; the modularity of the networks was found to be 0.28–0.42. Modularity (Q)
measures the quality of a network division into communities from the number of edges found relative
to the number expected if placed at random. The modularity value lies in the range 0, which indicates
clustering no better than random, to 1, with typical values for real networks ranging from 0.3 to 0.7 [42].
Enrichment for biological process and cellular component was performed using the topGO
package (https://bioconductor.org/packages/release/bioc/html/topGO.html), while functional
enrichment of synaptic proteins/gene groups that are known risk factors for schizophrenia was
performed using the published schizophrenia risk factor dataset [44].
The stability of all interactions across the region were assessed by comparison of clustering
results for each of seven region-specific networks and assigning each interaction a score of 0 if both
proteins appeared in the same cluster and a score of 1 if it appeared in a different cluster. Scores were
summed over all seven regions, resulting in sums ranging from 0 (proteins remain in the same
cluster in all regions) to 7 (proteins never appear in the same cluster). For the “stable” network,
we selected interactions with scores ≤2, which means that they persist in the same cluster in 5/7 (70%)
regional networks.
PPI networks were visualized with Gephi (https://gephi.org).
For disease enrichment analysis, the community and protein robustness values within the range
0–1 were taken as edge weights. Each region network was then clustered and cluster enrichment was
assessed using the TopOntop package (https://github.com/hxin/topOnto) and OMIM/Ensemble
Var/genetic annotation data. For disease enrichment the annotation data were standardized
using MetaMap [45–47] and NCBO Annotator (https://www.bioontology.org/annotator-service)
to recognize terms found in the Human Disease Ontology (HDO) [48]. Recognized enriched
disease ontology terms were then associated with gene identifiers and stored locally. Disease
term enrichment could then be calculated using the topology-based elimination Fisher method [49]
found in the topGO package (http://topgo.bioinf-mpi-inf.mpg.de/), together with the standardized
OMIM/GeneRIF/Ensembl variation gene-disease annotation data (17,731 gene-disease associations),
and the full HDO tree (3140 terms). Each region was then examined individually by performing the
clustering analysis and enrichment for each of the clusters identified in each of the seven brain regions.
3. Results
3.1. Quantification of Postsynaptic Proteins from Brain Regions
Seven integral brain regions within the forebrain (prosencephalon) and hindbrain (rhombencephalon)
were dissected from six eight-week-old C57BL/6J mice (Figure 1A and Figure S1). Forebrain regions
included telencephalic structures: frontal cortex (CxF), medial cortex (CxM), caudal cortex (CxCA),
hippocampus (Hip), and striatum (ST); the hypothalamus (Hyp) represented a diencephalic structure;
and the hindbrain was represented by cerebellum (CB). These represent major brain regions with
different structural and functional attributes and which can be relatively easy dissected from the brain.
PSD fractions were prepared from six mice and all 42 samples were analyzed using LC-MS/MS.
Label-free quantitation of peptide intensity identified 1173 proteins across all seven brain regions
(Table S1). We found a significant overlap between our dataset and those obtained in other mouse
studies [4–6,10–12,22] (Figure S2A,B); the 61 proteins unique to this study are summarized in Table S2.
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To determine the validity of pooling data from six mice, we performed several analyses. We first
used the differential stability (DS) approach, which has been previously applied to transcriptomic and
proteomic analyses of adult human brain regions [25,50] (Table S3). For this, we estimated the average
pairwise Pearson correlation to identify the proteins that demonstrate similar patterns across all six
brains. From 1173 synaptic proteins, roughly half (572) displayed a high DS correlation, or similar
expression patterns across all brain regions (Table S3A,B). We found that these were functionally
enriched in synaptic transmission proteins (q = 8.25 × 10−19), ATP metabolic processes (q = 1.33
× 10−12) and calcium ion transporting proteins (q = 2.02 × 10−9). Proteins involved in pathways
associated with learning (q = 8.08 × 10−6), memory (q = 6.23 × 10−3) and behavior (q = 1.39 × 10−7)
were also over-represented in this high DS subset. Components of several KEGG pathways were also
highly correlated between individuals, including long-term potentiation (q = 7.95 × 10−7), calcium
signaling pathways (q = 1.13 × 10−5), Huntington’s (q = 2.66 × 10−7), Alzheimer’s (q = 2.14 × 10−5)
and Parkinson’s disease (q = 8.95 × 10−6) (Table S3C). The most highly conserved proteins among
the six individual mice with the highest DS values were STX1A (p = 0.96), STUM (p = 0.96), CDH13
(p = 0.95) and ATP1B2 (p = 0.95) (Table S3B). We also compared the distribution of synaptic protein
abundances across individual mice by principal component analysis (PCA). This analysis (Figure
S3A) indicates that the synaptic proteome of the mice largely overlap, with brains A–C corresponding
to the central region of the distribution. As Tukey’s HSD test shows no significant difference in the
mean values of six individuals at a confidence level of 95% (Figure S3B), we determined that the data
from all six individuals could be combined and the mean protein abundances were then used for all
downstream analyses.
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(74%) proteins were found to be differentially expressed in at least one region compared with all 
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Figure 1. Signatures of postsynaptic proteome composition in mouse brain regions. (A) Seven
integral brain regions in mouse: frontal cortex (CxF), medial cortex (CxM), caudal cortex (CxCA),
hippocampus (Hip), striatum (ST), hypothalamus (Hyp), and cerebellum (CB). Color coded according
to vertebrate embryologic l regions ( s in (B)). (B) Hierarchical clustering by region (x-axis) and
protein abundance (y-axis) shows that each region has a unique si nature of postsynaptic proteome
composition. (C) Neuroanatomical map of clusters in (B) showing proteome organization into forebrain
and hindbrain structures: telencephalon, diencephalon and rhombencephalon.
3.2. Regional Differences in Postsynaptic Proteome Composition
To identify postsynaptic proteins with differential expression between brain regions, proteins
having a mean peptide intensity of 1.5-fold or greater in one brain region compared with any other
and determined to be significant with p < 0.05 were identified (Table S4). Eight hundred sixty-eight
(74%) proteins were found to be differentially expressed in at least one region compared with all
others (Table S4). T e regions with the largest number of differentially expressed proteins were the
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cerebellum (251), hypothalamus (243) and striatum (161). By contrast, the frontal (14), medial (70)
and caudal cortex (34) were found to contain the lowest number of differentially expressed proteins
compared with all other regions (Figure 1C).
Hierarchical clustering of all proteins revealed that each region has a unique signature of
expression. Moreover, these signatures are organized in line with the classical anatomical architecture
of the brain: the three cortical regions showed greatest similarity, and the next most similar region
was the hippocampus, then striatum, hypothalamus and cerebellum (Figure 1B). This clustering
reflects the embryological divisions of the vertebrate brain into telencephalon, diencephalon and
rhombencephalon (Figure 1C). Moreover, these results complement findings in the human neocortex,
where unique signatures were also found for each region. Together, these findings indicate that
compositional differences in the postsynaptic proteome reflect, at least in part, the embryological
patterning mechanisms that define brain regions.
This clustering approach also allowed us to examine region-specific functions. We identified six
sets of proteins, which we call postsynaptic proteome modules (PPM 1–6) (Figure 1B and Table S5).
As indicated by the clustering and Circos plots (Figure S4), these PPMs were differentially distributed
in brain regions. To understand the functional significance of differential protein expression in modules
and regions, we analyzed the KEGG biochemical and disease pathways in PPMs (Figure 2A). The PPMs
showed differential composition of pathways. For example, neurodegenerative diseases were found in
PPM1, whereas synaptic plasticity (long-term potentiation and long-term depression) and relevant
signaling pathways were in PPM2.
Examination of KEGG pathway enrichment in brain regions (Figure 2B) revealed three major
groups. It is striking that very similar groupings were observed in the analysis of human
neocortical regions. Group 1 contained terms including MAPK, chemokine, neurotrophin pathways;
Group 2 included synaptic plasticity mechanisms and calcium signaling; and Group 3 included
neurodegenerative diseases (Alzheimer’s, Huntington’s, and Parkinson’s) and metabolic mechanisms
(glycolysis/gluconeogenesis and oxidative phosphorylation). These findings suggest that biochemical
pathways in the postsynaptic proteome are differentially distributed across brain regions and that the
mechanisms controlling this distribution are species conserved.
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Figure 2. Biochemical pathways and functions in brain regions and postsynaptic proteome modules
(PPMs). (A) KEGG pathway term (y-axis) enrichment in PPMs (x-axis) with the number of proteins
contributing to KEGG enrichment indicated in brackets. Size of the dots represents the number of
genes associated with that pathway (GeneRatio) and the significance indicated by the p-adjust color bar.
(B) Heatmap of the KEGG biochemical athway and disease enr chment terms (y-axis) based on the
ranked abundance of postsy aptic proteins in each region (x-axis). Three clusters of KEGG terms are
boxed: (1) many signal transduction mechanisms; (2) synaptic plasticity and other signaling processes;
and (3) neurodegenerative diseases and metabolic mechanisms.
3.3. Distribution of Mechanism of Cognition and Protein Complexes
The seven regio s of the brain examined in this study are tho ght to play distinct but
interdep ndent roles i cognitive function. Therefore, we xamined the dist bution of 33 selected
proteins that are known to play roles in cognition (Figure 3A). Hierarchical clustering shows that the
three cortical regions examined (CxF, CxM, and CxCA) cluster together by similarity, while the Hip
region clusters separately from all others. The Hyp and ST regions cluster together by similarity in
their abundances of proteins involved in memory and cognition, while the CB clusters separately
from all of the other six regions. The abundances of these proteins clustered into two main branches
(Figure 3A).
To a sess the h terogeneity of synaptic protein complexes throughout the brain, the abundances
of the four MAGUK scaffold protein paralogs Dlg1 (also k own as Sap97), PSD93 (Dlg2),
Dlg3 (also known as Sap102) and PSD95 (Dlg4) were mapped across the various brain regions.
We found that these four molecules, which play fundamental roles in synaptic transmission,
were differentially distributed throughout the brain, with Dlg1 being most abundant in the synapses of
the CxM and PSD93 most abundant in Hip, CxCA and CxF. By contrast, both Dlg3 and PSD95 showed
similar protein abundance profiles across the various brain regions (Figure 3B).
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3.4. orrelations of egional Synapse Proteo es ith the onnecto e
There are large-scale efforts to map the mouse brain connectome by identifying the projections of
neurons between brain regions [37,51]. Because these connections are made at synapses, it follows that
there may be a relationship between the molecular composition of synapses in one region and their
interconnections. To address this, we asked if the synaptic proteins quantified in this study correlated
with connectivity data from the Allen Brain Institute’s Mouse Brain Connectivity Atlas (mesoscale
connectome) [37] (Figure 4, and Table S6). Hierarchical clustering of postsynaptic proteome abundance
and connection strength approximated from projection volume shows that regional connections are
associated with distinct signatures of proteins. Moreover, two major branches separated cortex,
striatum and hippocampus from cerebellum and hypothalamus, suggesting that hindbrain and basal
forebrain connections have broadly distinct molecular properties compared with connections of other
forebrain structures.
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We found that, in the hippocampus, Dlg3, PSD93 and PSD95 but not Dlg1 were highly correlated
(R2 = 0.7–0.8) with projection volume (Table S6). We then asked if the biochemical pathways that
underlie brain connectivity were brain region specific, and performed functional enrichment on the
synaptic proteins that were highly correlated (R2 ≥ 0.6) with neuron projection volume for each
region. Pathways associated with glutamatergic synapses, calcium signaling, long-term potentiation
(LTP), long-term depression (LTD) and insulin signaling were over-represented in the hippocampus,
striatum and cortical regions, whereas pathways involved in Parkinson’s, Huntington’s and oxidative
phosphorylation and mitochondrial components were enriched in the cerebellum and hypothalamus.
Additionally, the molecular correlates of connectivity in the hippocampus are uniquely enriched in
endocytosis (q = 4.09 × 10−9) and GABAergic synapses (q = 7.53 × 10−3), the cortical regions in
components of the TCA cycle (q = 1.72 × 10−3) and the cerebellum in valine, leucine and isoleucine
degradation pathways (q = 1.11 × 10−6) and fatty acids metabolism (q = 4.6 × 10−4) (Table S7A–E).
Together, these findings indicate that synapse proteome composition may reflect functional differences
between interconnected brain regions.
3.5. Regional Differences in Postsynaptic Protein Interaction Networks
The organization and function of synapse proteomes have been studied using protein-protein
interaction (PPI) networks [18,22,52,53] and we used this approach to explore the organization of
protein interaction networks in different brain regions. First, the total postsynaptic proteome network
was built from the list of proteins obtained in this study and PPIs obtained by mining publicly available
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databases: BioGRID [38], IntAct [39] and DIP [40] for both mouse and human. The total network
consists of 1016 proteins and 8105 PPIs. Using the differential abundance of proteins as an edge weight,
we constructed individual networks for each region, identified clusters and their corresponding
enrichments in biological and disease functions (Table S8). We found that each region-specific PPI
network was split by the same method into a different number of clusters (cl. N), ranging from 82
to 112 clusters (results for a spectral clustering algorithm are shown in Table S8). We assessed the
clustering structure of each region’s PPIs for robustness and the resulting (consensus) clusters were
examined for disease enrichment (Table S9).
Examination of disease enrichment showed that some diseases impact clusters across all brain
regions whereas others had more discrete regional effects. For example, all brain regions (except CxF)
contained one highly significantly enriched cluster for autism spectrum disorder (adjusted p-values
as follows): CB (cl. 19, p = 9.77 × 10−8), CxCA (cl. 9, p = 9.77 × 10−8), CxM (cl. 10, p = 2.76 × 10−6),
Hip (cl. 53, p = 4.84× 10−7), Hyp (cl. 48, p = 3.77× 10−6) and ST (cl. 24, p = 8.17× 10−3). We also found
clusters associated with intellectual disability (ID) to be enriched in the CB (cl. 19, p = 4.36 × 10−5)
and the ST (cl. 25, p = 6.64 × 10−5). We found that PPI clusters associated with bipolar disorder were
moderately enriched in the CxF (cl. 50, p = 1.44 × 10−2) and Hyp (cl. 66, p = 2.05 × 10−2), while those
associated with schizophrenia were highly enriched in the CB, CxCA and CxM (cl. 10, p = 1.29 × 10−6;
cl. 9, p = 4.41 × 10−6; and cl. 10, p = 2.90 × 10−5, respectively) (see Table S9 for all disease enrichment
results).
We found regional variability in enrichment levels for neurodegenerative diseases. For Alzheimer’s
disease, the most enriched cluster was in the Hip (cl. 53, p = 7.97 × 10−6), while for Parkinson’s disease
a moderate enrichment occurred in the CxCA (cl. 32, p = 6.64 × 10−3). Clusters associated with
dementia were significantly enriched only in the Hyp (cl. 6, p = 4.63 × 10−5).
3.6. Identifying a Stable Core Network
To define the network structures that are conserved across all brain regions, we identified
4205 binary interactions (52% of total) that were found in the same cluster in the majority of regional
networks. We refer to this as the “stable” postsynaptic density (PSD) (1016 proteins, Figure 5 and
Table S10). Spectral clustering generated 73 clusters in total, where the nine largest represent crucial
synaptic proteins and neural housekeeping functions: cl. 37 corresponds to the postsynaptic signaling
complexes composed of MAGUK scaffold proteins, AMPA and NMDA receptors [23], and other
clusters contain ribosomal, metabolic enzymes and actin/myosin-associated proteins (Figure 5,
Table S10). We compared the composition of these stable communities with previously detected PPMs
and found significant overlaps. For example, cl. 1 containing ATPase and cytochrome-related proteins
and cl. 8 containing mitochondrial complex I proteins were over-represented in protein module PPM1
associated with related terms (p = 4.5 × 10−4 and p = 9.3 × 10−5, respectively); cl 4 is composed
mainly of metabolic enzymes and falls almost entirely in to PPM1 associated with Parkinson’s disease,
Alzheimer’s disease and metabolic pathways by KEGG pathway enrichment (Figure 5; p = 7.5 × 10−5).
Molecules involved in memory and cognition (e.g., MAGUKs) that populated cl. 6 are distributed
between PPM5 (p = 8.0× 10−3) and PPM4 (p = 1.9× 10−2) associated with the terms “neurotransmitter
receptor binding and downstream transmission in the postsynaptic cell”, “long-term potentiation”
and “long-term depression”.
Proteomes 2018, 6, 31 12 of 18
Proteomes 2018, 6, x 12 of 18 
 
 
Figure 5. Postsynaptic proteome interaction network showing the cluster structure for the “stable 
network”. A few large clusters with specific functionally related proteins could be detected: cl. 3 
contains ribosomal proteins (red cluster at the bottom), cl. 4 contains metabolic enzymes (light green 
on the left), cl. 7 is enriched with actin-, myosin- and cytoskeleton remodeling-associated proteins 
(dark blue near the top), cl. 8 contains NADH-oxidoreductases (dark-red cluster on the right) and cl. 
1 contains ATPases and voltage-dependent anion channels (light blue on the right). cl. 6 corresponds 
to key proteins involved in synaptic transmission and plasticity, including AMPA, NMDA receptors 
and MAGUK proteins (orange cluster at the top). Networks were visualized with Gephi. 
4. Discussion 
Using mass spectrometry we have examined the protein composition of the postsynaptic 
proteome of excitatory synapses from regions of the mouse brain and generated a freely available 
data resource (Edinburgh DataShare, http://dx.doi.org/10.7488/ds/1713). We found that a high 
percentage of proteins show abundant differences between brain regions. The postsynaptic proteome 
composition for each brain region forms a distinctive molecular signature. Because these proteomic 
data were obtained from tissue samples composed of many individual synapses, the proteomic 
signatures indicate that there might be synapse diversity at the single-synapse level. Consistent with 
this, we have recently examined the differential distribution of PSD95 and SAP102 in individual 
synapses across the whole mouse brain and found that these two proteins are differentially 
Figure 5. Postsynaptic proteome interaction network showing the cluster structure for the “stable
network”. A few large clusters with specific functionally related proteins could be detected: cl. 3
contains ribosomal proteins (red cluster at the bottom), cl. 4 contains metabolic enzymes (light green
on the left), cl. 7 is enriched with actin-, myosin- and cytoskeleton remodeling-associated proteins
(dark blue near the top), cl. 8 contains NADH-oxidoreductases (dark-red cluster on the right) and cl. 1
contains ATPases and voltage-dependent anion channels (light blue on the right). cl. 6 corresponds to
key proteins involved in synaptic transmission and plasticity, including AMPA, NMDA receptors and
MAGUK proteins (orange cluster at the top). Networks were visualized with Gephi.
4. Discussion
Using mass spectrometry we have examined the protein composition of the postsynaptic proteome
of excitatory synapses from regions of the mouse brain and generated a freely available data resource
(Edinburgh DataShare, http://dx.doi.org/10.7488/ds/2399). We found that a high percentage of
proteins show abundant differences between brain regions. The postsynaptic proteome composition for
each brain region forms a distinctive molecular signature. Because these proteomic data were obtained
from tissue samples composed of many individual synapses, the proteomic signatures indicate that
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there might be synapse diversity at the single-synapse level. Consistent with this, we have recently
examined the differential distribution of PSD95 and SAP102 in individual synapses across the whole
mouse brain and found that these two proteins are differentially distributed into synapse subtypes [26].
Moreover, each brain region was composed of varying proportions of synapse subtypes, which results
in each region having a “signature of subtypes”. Together, these findings indicate that postsynaptic
proteome diversity seen at the level of brain regions arises at the individual synapse level.
The advantage of proteomic mass spectrometry is that it examines the expression of large
numbers of proteins and can therefore shed light on how sets of proteins are expressed. We found
regional diversity in sets of proteins known to be associated with biochemical pathways controlling
physiological processes (such as forms of synaptic plasticity and cognition) and diseases. We also
found evidence that scaffold proteins involved with the supramolecular assembly of complexes and
supercomplexes [20,23] were differentially distributed across the brain.
The analysis of weighted PPI networks supports previous findings that the postsynaptic proteome
has a modular structure [52]. We now find that the regional variability of protein complex composition
strongly depends on the relative protein abundance, thereby providing the heterogeneity and unique
biochemical signaling potential of each region. In each brain region, we find that ~60% of the
complexes/clusters are conserved in a stable network and that ~40% underpin regional specifications.
Disease enrichment analysis, which was performed at the regional level, tends to identify the same
clusters. Regional specificity results in effectively the same cluster being more or less enriched for each
disease across the different brain regions.
The coordinate expression of sets and modules of proteins suggests the possibility that there is
an underlying genetic mechanism coordinating the spatial expression of synapse proteins. Evidence
in support of a coordinating genetic mechanism acting in the temporal domain was provided from
transcriptome analyses of developing cultured neurons [54] and lifespan expression data in the brain
of mouse and human [2], which show concerted regulation of postsynaptic proteins. Further evidence
for an underlying genetic program regulating the differential spatial expression comes from the
hierarchical clustering of protein expression that reveals a correlation with the early development
of the nervous system. A similar result was obtained using the single-synapse resolution mapping:
the regional signatures of synapse composition in the adult mouse brain are organized into three
major groups corresponding to the earliest division of the neural tube [55]. The clustering of the
hippocampus, a subcortical region, with cortical regions likely reflects their common developmental
origins [55]. These multiple lines of evidence suggest that there is temporal and spatial regulation of
postsynaptic proteome expression and that it produces diversity of synapse types [26].
The purpose of regional diversity is most likely to subserve region-specific physiological
and behavioral functions. It might also be to provide regional specializations within the greater
systems-level organization or global circuitry of the brain. Our analysis of connectome data indicates
that the anatomical circuitry of the brain links areas with distinct synapse proteome compositions.
Given the differences in biochemical pathways, this indicates that functional specializations in regions
are integrated by the connectome. This is consistent with our recent findings showing that the regional
composition of the neocortex is linked to behavioral functions observed using functional magnetic
resonance imaging (fMRI) [25].
It is interesting that hypothalamus and striatal regions cluster together in protein abundance,
whereas the cortex, striatum and hippocampus were separate from the cerebellum and hypothalamus
when abundance and connection strength was analyzed. The protein abundance and connection
strength correlation between the hypothalamus and cerebellum might relate to the involvement of
these structures in several shared biological functions. For example, the cerebellum is known to
be interconnected with the hypothalamus, an important center for feeding control, through direct
bidirectional connections [56–58]. Most of the hypothalamic neurons receiving cerebellar projections
are feeding related. The reciprocal connections between the cerebellum and hypothalamus might
therefore play an important role in feeding motivation and in the regulation of feeding behavior [59].
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Numerous forms of dementia show pathology in different regions of the brain. For example,
dementia with Lewy bodies, which is the second most common form of neurodegenerative dementia
after Alzheimer’s disease [60], shows hypothalamic atrophy, potentially relevant to the enrichment of
dementia pathways observed in this region, whereas this region is not affected in Alzheimer’s disease
patients [61]. Although the severe pathology of Huntington’s disease is mostly related to the striatum,
important changes in the hypothalamus and cerebellum have also been described [62], consistent with
the observed enrichment of their respective disease pathways in these areas. Homeostatic control of
emotions and of metabolism are disturbed early in Huntington’s disease and there are alterations in the
peptide expression of hypothalamic neurons known to be involved in the regulation of metabolism and
emotion [63]. In cerebellum, a dysfunction of the Purkinje cells might contribute to motor impairment
in a murine model of Huntington’s disease [64], and the cerebellum appears to be commonly affected
in juvenile Huntington’s disease, as shown by a decrease of cerebellar volume [65–67]. The enrichment
of Parkinson’s disease pathways in hypothalamus is interesting since alterations in hypothalamus
have been linked to non-motor symptoms such as sleep disturbances [68]. Furthermore, the cerebellum
is known to be involved in Parkinsonian disorders with motor symptoms [69].
In conclusion, we provide a new data resource describing the composition of the postsynaptic
proteome in excitatory synapses from regions of the mouse brain. These data indicate that molecular
compositional differences in synapses in different brain regions are relevant to a broad range of
physiological and disease processes.
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